Both types of ATP receptors, ionotropic (P2X) and metabotropic (P2Y), are widely distributed in the brain (Ralevic and Burnstock, 1998) . The P2X receptors comprise a family of ATP-gated nonselective cation channel-receptors that mediate fast excitatory transmission in some peripheral nervous system and CNS pathways (Ralevic and Burnstock, 1998) and also have a neuromodulatory role, particularly at the presynaptic level (reviewed in Cunha and Ribeiro, 2000a) . Seven subtypes of P2X receptors have been cloned (P2X 1-7 ) (North and Surprenant, 2000) , of which P2X 1 , P2X 2 , P2X 4 and P2X 6 have overlapping expressions in the brain (Valera et al., 1994; Collo et al., 1996; Sé gué la et al., 1996; Soto et al., 1996; Tanaka et al., 1996; Lê et al., 1998a) . In fact, localisation of ATP receptors by radioligand binding techniques (Bo and Burnstock, 1994; Balcar et al., 1995) , in situ hybridisation (Valera et al., 1994; Kidd et al., 1995; Collo et al., 1996; Soto et al., 1996; Tanaka et al., 1996; Lê et al., 1998a) and immunocytochemistry (Lê et al., 1998b; Kanjhan et al., 1999; Worthington et al., 1999; Rubio and Soto, 2001) show a broad distribution of P2X receptors in the brain, with the hippocampus being one of the areas expressing the highest levels.
However, in the hippocampus and in other brain structures where P2X receptors are abundantly expressed, the neuroactive role of ATP is still ill-defined. In fact, ATPergic transmission has been demonstrated in the medial habenula (Edwards et al., 1992) , in the spinal cord (Bardoni et al., 1997) , in the locus coeruleus (Nieber et al., 1997) and in the nucleus tractus solitarius (Thomas and Spyer, 2000) whereas in the hippocampus it only contributes to less than 10% of excitatory transmission in glutamatergic synapses (Pankratov et al., 1998; Mori et al., 2001) . When probing the effect of extracellular ATP, it is mostly concluded that its main role is to act as a substrate for ecto-nucleotidases yielding adenosine (Dunwiddie et al., 1997; Cunha et al., 1998) , a neuromodulator on its own (reviewed by Cunha, 2001) . In fact, the inhibitory effect of ATP on basal hip-*Corresponding author. Tel: ϩ35-1-239-820190; fax: ϩ35-1-239-822776. E-mail address: racunha@clix.pt (R. A. Cunha). Abbreviations: aCSF, artificial cerebrospinal fluid; CGS 21680, 2-[4-(2-p-carboxyethyl)phenylamino]-5Ј-N-ethylcarboxamidoadenosine; DMSO, dimethylsulphoxide; 1, DPCPX, 1, ; fEPSP, field excitatory post-synaptic potential; ␤,␥-Imido ATP, 5-adenylylimido-diphosphate; LTP, long-term potentiation; ␣,␤-MeATP, ␣,␤-methylene ATP; NBTI, NF023, naphthalene-1,3,5-trisulfonate; PPADS, pyridoxal phosphate-6-azophenyl-2,4-disulphonic acid; SCH 58261, 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo [1,5-c] pyrimidine; XAC, amino]carbonylmethyl-oxyphenyl}xanthine; ZM 241385, 4-(2-[7-amino-2-(2-furyl) [1, 2, 4] triazolo [2,3-a] [1, 3, 5] triazin-5ylamino]ethyl)phenol.
pocampal synaptic transmission is abolished in adenosine A 1 receptor knockout animals (Masino et al., 2002) .
But, interestingly, ATP is released in greater amounts upon conditions of high frequency stimulation Cunha et al., 1996a ) associated with phenomena of synaptic plasticity. Use-dependent long-term changes in synaptic efficiency, like long-term potentiation (LTP), are thought to form the basis for learning and memory (Bliss and Collingridge, 1993) . In hippocampal CA1 neurons, extracellularly applied ATP causes synaptic potentiation similar to LTP (ATP-induced LTP; Wieraszko and Ehrlich, 1994; Fujii et al., 1995; O'Kane and Stone, 2000) . This may occur either because extracellular ATP can play a role in ATP-induced LTP as a orthophosphate donor for the extracellular phosphorylation of membrane proteins (Fujii et al., 1995; Chen et al., 1996) or because ATP may directly control neuronal function by activating hippocampal P 2 receptors (Inoue et al., 1996; Pankratov et al., 1998 Pankratov et al., , 2002 Mori et al., 2001) .
We re-evaluated the modulatory role of extracellular ATP on synaptic plasticity in hippocampal slices now 1) controlling for the possibility that some effects may be due to the formation of adenosine, 2) using ATP analogues not prone to act as phosphate donors, and 3) choosing a -burst pattern to induce LTP, since modulatory effects may not be observed with robust high-frequency stimulation protocols (de Mendonça and Ribeiro, 2001 ).
EXPERIMENTAL PROCEDURES Drugs
Adenosine deaminase (type VI; 1803 U/ml; EC 3.5.4.4), S-(pnitrobenzyl)-6-thioinosine (NBTI), ␣,␤-methylene ATP (␣,␤-MeATP) and 5-adenylylimido-diphosphate (␤,␥-Imido ATP) were from Sigma (Reagente 5, Porto, Portugal), 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), 8-{4-[(2-aminoethyl)amino]carbonylmethyl-oxyphenyl}xanthine (XAC), suramin, 2-[4-(2-p-carboxyethyl)-phenylamino]-5Ј-N-ethylcarboxamidoadenosine (CGS 21680), pyridoxal phosphate-6-azophenyl-2,4-disulphonic acid (PPADS), and 8-(benzamido)naphthalene-1,3,5-trisulfonate (NF023) were from RBI (Reagente 5, Porto, Portugal), dipyridamole was from Boehringer Ingelheim, 4-(2-[7-amino-2-(2-furyl) [1, 2, 4] triazolo [2,3-a] [1, 3, 5] triazin-5ylamino]ethyl)phenol (ZM 241385) was from Tocris, 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine (SCH 58261) was a kind gift of E. Ongini (Shering-Plough, Milan), [2,3,8Ј-3 H]adenosine (specific activity: 55.8 Ci/mmol) and [ 3 H]CGS 21680 (specific activity 38.4 Ci/mmol) were from DuPont NEN (Anagene, Lisbon, Portugal) and chelerythrine and H89 were from Calbiochem (Darmstadt, Germany).
ZM241385, CGS 21680, XAC, dipyridamole, NBTI, H89 and chelerythrine were made up as 5 mM stock solutions in dimethylsulphoxide (DMSO). SCH 58261 was made up as a 10 mM stock solution in DMSO. DPCPX was made up into a 5 mM stock solution in 99% DMSO and 1% NaOH (1M). All drug stock solutions were diluted directly into the superfusion solution to the appropriate final concentration. DMSO, in the maximal concentration applied to the preparations, was devoid of effects on synaptic plasticity experiments and [ 3 H]adenosine release from rat hippocampal slices.
Preparation of hippocampal slices
The experiments were performed on hippocampal slices taken from male young adult Wistar rats (5-6 weeks old, from Harlan Iberica, Barcelona, Spain) that were handled and killed according to EU guidelines, the number of animals used being kept to an absolute minimum for the results to reach statistical significance. To minimise suffering, the animals were anaesthetized with halothane before being decapitated, and the right hippocampus was dissected free within an ice-cold artificial cerebrospinal fluid (aCSF) of the following composition (in mM): NaCl 124, KCl 3, NaH 2 PO 4 1.25, NaHCO 3 26, MgSO 4 1, CaCl 2 2, glucose 10, and gassed with a 95% O 2 and 5% CO 2 mixture. Slices were cut 400 m thick perpendicularly to the long axis of the hippocampus with a McIlwain tissue chopper, and kept in a resting chamber within the same gassed aCSF at room temperature (22°C-25°C) for at least 1 h to allow their energetic and functional recovery.
Electrophysiology studies
A slice was transferred to the submerged recording chamber (1 ml capacity) where it was continuously superfused at a rate of 3 ml/ min with the same gassed solution at 30.5°C. Stimulation (rectangular pulses of 0.1 ms) was delivered through a bipolar concentric wire electrode placed on the Schaffer collateral/commissural fibers in the stratum radiatum. Two separate sets of the Schaffer pathway (S1 and S2) were stimulated, as previously described (Costenla et al., 1999) . Responses were evoked alternately on the two pathways, each pathway being stimulated once every 20 s (basal frequency). The initial intensity of the stimulus was that eliciting a field excitatory post-synaptic potential (fEPSP) of about 1 mV amplitude, whilst minimising contamination by the population spike, and of similar magnitude in both pathways. Evoked fEPSP were recorded extracellularly from CA1 stratum radiatum using micropipettes filled with 4 M NaCl and 2-6 M⍀ resistance, and displayed on a Tektronix digitising oscilloscope. The averages of eight consecutive responses from each pathway were obtained, plotted graphically and recorded for further analysis with a personal computer using locally developed software. The fEPSP were quantified as the slope of the initial phase of the potential. The independence of the two pathways was tested by using paired-pulse facilitation across both pathways, less than 10% facilitation being usually observed.
LTP was induced by a -burst stimulation pattern (three trains of 100 Hz, each with four stimuli, separated by 200 ms). In all the experiments, the stimulation protocol to induce LTP was applied after having a stable baseline for at least 30 min. LTP was quantified as the percentage change in the average slope of the potentials taken from 50 to 60 min after the induction protocol, in relation to the average slope of the fEPSP measured during the 10 min that preceded the induction protocol. LTP was always induced in one pathway in the control conditions, and afterward induced in the other pathway, in the presence of the drug to be tested. It is important to note that the use of two stimulation pathways to compare the effects of drugs on -burst-induced LTP is particularly important since there is a large variation in the amplitude of LTP between slices, whereas we confirmed that LTP amplitudes obtained on stimulation of two independent sets of Schaffer pathways are similar.
[ 3 H]adenosine release studies
The release of [ 3 H]adenosine from rat hippocampal slices was performed as previously described (Cunha et al., 1996a) . Briefly, the slices were resuspended in 2 ml of oxygenated aCSF, equilibrated at 37°C for 10 min and loaded with [2,3,8Ј- 3 H]adenosine (30 Ci/ml, 0.125 M) for 20 min. The excess of radioactivity was removed by washing the preparations twice with 2 ml of oxygenated aCSF at 37°C. Groups of three slices were then placed in 100 l chambers and superfused with oxygenated aCSF at 37°C with a flow rate of 0.6 ml/min. After 30 min superfusion, the effluent was collected every 2 min to quantify released tritium. When the effect of any drug was tested, this drug was added 6 min after the sample collection was started, only into two chambers out of four chambers, and remained in the bath until the end of the release period. At the end of the experiments (22 min after starting the sample collection), the slices were sonicated in 0.5 ml of 3 M perchloric acid with 2% Triton X-100, and a 100 l aliquot of the homogenised slices was used to determine the amount of tritium retained by the preparations (Cunha et al., 1996a) . The release of [ 3 H]adenosine from rat hippocampal synaptosomes followed a protocol similar to that used for slices, as previously described (Cunha et al., 2000) , using 0.4 -0.6 mg of protein in each assay.
The release of [ 3 H]adenosine from primary cultures of rat hippocampal neurons or astrocytes was also evaluated. Hippocampal neurons were dissociated from hippocampi of E18 -E19 rat embryos, as previously described (Ambró sio et al., 1999) and cultured in serum free Neurobasal medium (GIBCO, Life Technologies, UK) with B27 supplement (GIBCO), 25 M glutamine, 0.5 mM glutamate and 0.12 mg/ml gentamicin. Cultures were plated on poly-D-lysine-coated (0.1 mg/ml) glass coverslips at a density of 0.2ϫ10 6 cells/cm 2 and kept at 37°C in a humidified incubator in 5% CO 2 /95% air for 7-8 days, the time required for maturation of hippocampal neurons. Cultured astrocytes were obtained from P5 rat pups and cultured in a humidified incubator in 5% CO 2 /95% air for 10 -14 days at 37°C on poly-D-lysinecoated (0.1 mg/ml) 75 cm 2 Costar containers at a density of 1.14ϫ10 5 cells/cm 2 in Dulbecco's Modified Eagle medium (GIBCO) supplemented with 100 g/ml streptomycin, 100 U/ml penicillin and 10% foetal calf serum (Seromed; e.g. Saneto and de Vellis, 1987) . These cultures of neurons or astrocytes were incubated for 4 h at room temperature with aCSF solution buffered with 25 mM HEPES (aCSF-HEPES solution) and then incubated for a further 30 min period with [2,3,8Ј-3 H]adenosine (30 Ci/ml, 0.125 M). They were then superfused for 90 min at a flow rate of 0.5 ml/min with aCSF-HEPES solution to remove non-incorporated radioactivity, the excess of medium being removed by vacuum suction to ensure a constant volume of 2 ml (neurons) or 5 ml (astrocytes). Drugs were added through this superfusion solution and tritium release was quantified in the collected vacuum aspirate after exposure of the cultures for 15 min to the tested drugs. At the end of the experiment, the cultured neurons or astrocytes were incubated with 0.5 or 2 ml of 3 M perchloric acid with 2% Triton X-100, and a 100 l aliquot of the supernatant was used to determine the amount of tritium retained by the preparations.
Radioactivity was expressed in terms of disintegrations per second per milligram of protein (Bq/mg) in each chamber, protein being quantified by the method of Peterson (1977) . In some experiments, a 500 l aliquot of the collected sample was separated by HPLC and the peak corresponding to adenosine was collected to quantify [ 3 H]adenosine outflow, as previously described (Cunha et al., 1996a) .
Binding to adenosine A 2A receptors
The competition by ATP analogues (1-1000 M) of [ 3 H]CGS 21680 binding was performed as previously described (Cunha et al., 1996b) using membranes from the rat hippocampus. Briefly, [ 3 H]CGS 21680 (30 nM) binding was carried out for 4 h at room temperature (23-25°C), with 242-310 g of membrane protein in a final volume of 300 l in an incubation solution containing 50 mM Tris-HCl and 10 mM MgCl 2 , pH 7.4, with 5 U/ml adenosine deaminase. Specific binding was determined by subtraction of the non-specific binding which was measured in the presence of 2 M XAC. The binding reactions were stopped by vacuum filtration through Whatman GF/C glass fibre filters, followed by washing of the filters and reaction tubes with 10 ml of the incubation solution, kept at 4°C. The filters were then placed in scintillation vials, and 5 ml of scintillation liquid (Scintran Cocktail T; Wallac, Turku, Finland) were added. Radioactivity bound to the filters was determined after 12 h with an efficiency of 55-60% for 2 min. Membrane protein was determined according to Peterson (1977) .
Statistical analysis
Values are presented as the meanϮS.E.M. The significance of the differences between the means was calculated with the two-tailed paired Student's t-test. Values of PϽ0.05 were considered to be statistically significant.
RESULTS

ATP analogues facilitate LTP when adenosine A 1 receptors are blocked
The application of -burst stimulation (three trains of 100 Hz, four stimuli, separated by 200 ms) in one pathway caused LTP with an amplitude of 36.4Ϯ8.7% (nϭ4). The application of a similar -burst stimulation in the other pathway in the presence of ␣␤-MeATP (20 M) elicited a smaller LTP (16.6Ϯ5.0%, nϭ4, PϽ0.05). This inhibitory effect of the ATP analog is similar to the inhibition of LTP by adenosine A 1 receptor activation (de Mendonça and Ribeiro, 1990) and it is known that, under basal conditions of stimulation, ATP analogues are locally catabolised into adenosine and channelled to A 1 receptor activation (Cunha et al., 1998) . In fact, the P2 receptor antagonists, PPADS (10 M) or suramin (75 M), did not modify the inhibitory effect of the ATP analog on LTP (the values of LTP were 29.0Ϯ5.0% in control solution and 14.0Ϯ5.3% in the presence of ␣␤-MeATP (20 M) and PPADS (10 M); and 21.5Ϯ5.2% in control solution and 12.2Ϯ5.1% in the presence of ␣␤-MeATP (20 M) and suramin (75 M; nϭ4, PϽ0.05). In contrast, in the presence of the selective adenosine A 1 receptor antagonist, DPCPX (50 nM), we no longer observed the inhibitory effect of the ATP analog. In fact, ␣␤-MeATP (20 M) facilitated LTP from 21.2Ϯ7.5% to 47.4Ϯ5.6% (nϭ5; PϽ0.05; Fig. 1A, B) . We also tested another ATP analog, ␤␥-Imido ATP (20 M), which did also facilitate LTP from 16.1Ϯ8% to 41.5Ϯ5.1%, in the presence of 50 nM DPCPX (nϭ4; PϽ0.05; Fig. 1C) . Thus, the inhibitory effects of the ATP analogues on LTP may be due to adenosine A 1 receptor activation rather than to a genuine P2 receptor-mediated effect. When blocking adenosine A 1 receptors, an excitatory effect of the ATP analogues on LTP became apparent. Therefore, to further investigate the role of P2 receptors in the modulation of LTP, all the subsequent experiments were performed under blockade of adenosine A 1 receptors with DPCPX (50 nM). To test the modification by different drugs of the facilitation by ATP analogues of -burst LTP, we always compared in two different pathways of the same slice the effect in the first pathway of DPCPX together with the tested drug (control) with the effect in the second pathway of the ATP analog in the presence of DPCPX and the tested drug. This enabled us to determine if the effect of the ATP analogues was modified by the tested drug in the same slice, irrespective of the effect of the tested drugs on LTP and on basal synaptic transmission. Again, it is important to stress that comparisons need to be carried out in the same slice since we noted a considerable variation of the amplitude of -burst LTP between slices.
ATP antagonists prevent the facilitatory effect of ATP analogues on LTP
We then tested the ability of antagonists of P2 receptors to modify the facilitatory effect of ATP analogues on LTPinduced by -burst stimulation pattern, observed in the presence of DPCPX (50 nM; Fig. 1 ). The facilitatory effect of ␣␤-MeATP (20 M) on LTP was prevented by the P2 receptor antagonist PPADS (20 M), a value of 14.6Ϯ1.6% being obtained in the presence of PPADS and ␣␤-MeATP compared with a value of 16.9Ϯ3.7% when ␣␤-MeATP was not present (nϭ3; PϾ0.05; Fig. 2A ). Likewise, the facilitatory effect of ␤␥-Imido ATP (20 M) on LTP was also prevented by the P2 receptor antagonist PPADS (20 M), a value of 15.1Ϯ2.4% being obtained in the presence of PPADS and ␤␥-Imido ATP compared with a value of 15.9Ϯ2.9% when ␤␥-Imido ATP was not present (nϭ3, PϾ0.05). The facilitatory effect of ␤␥-Imido ATP (20 M) on LTP was also prevented by another P2 receptor antagonist, suramin (75 M), a value of 15.1Ϯ1.7% being obtained in the presence of suramin and ␤␥-Imido ATP compared with a value of 17.6Ϯ2.0% when ␤␥-Imido ATP was not present (nϭ3; PϾ0.05; Fig. 2B ).
The pharmacological characterisation of the P2 receptors likely to be involved in the facilitation by ATP analogues of -burst induced LTP is problematic due to the poor selectivity of the P2 receptor ligands currently available (Ralevic and Burnstock, 1998) . But, since ␤␥-Imido ATP was equi-effective with ␣␤-MeATP, the later being considered a P2X 1/3 receptor preferring agonist (Ralevic and Burnstock, 1998) , we decided to test the ability of a purported P2X 1 /P2X 3 receptor antagonist, NF023 (Soto et al., 1999; Lambrecht, 2000) to prevent the facilitatory effect of ATP analogues. NF023 (10 M) blocked the facilitatory effect of ␤␥-Imido ATP (20 M) on LTP, a value of 25.6Ϯ10.6% being obtained in the presence of NF023 and ␤␥-Imido ATP and a value of 25.3Ϯ10.5% when ␤␥-Imido ATP was not present, (nϭ3; Fig. 2C ).
Adenosine A 2A antagonists prevent the facilitatory effect of the ATP analogues on LTP Since it has previously been shown that endogenously released adenine nucleotides lead to preferential activation of adenosine A 2A receptors (Cunha et al., 1996c) and activation of these A 2A receptors is known to facilitate LTP (de Mendonça and Ribeiro, 1994), we thought important to probe the participation of facilitatory adenosine A 2A receptors in this enhancement of LTP by ATP analogues.
Indeed, the A 2A receptor antagonists, ZM 241385 (50 nM) and SCH 58261 (50 nM) prevented the facilitatory effects of ␣␤-MeATP (20 M) and of ␤␥-Imido ATP (20 M) on LTP (see Fig. 3 ). Thus, a value for LTP of 18.2Ϯ0.7% was obtained in the presence of ZM 241385 and ␣␤-MeATP compared with a value of 17.9Ϯ0.3% when ␣␤-MeATP was not present (nϭ4; PϾ0.05; Fig. 3A) . when ␤␥-Imido ATP was not present (nϭ3; PϾ0.05). Finally, the facilitatory effect of ␤␥-Imido ATP (20 M) on LTP was also prevented by SCH 58261 (50 nM), a value of 24.2Ϯ3.6% being obtained in the presence of SCH 58261 and ␤␥-Imido ATP compared with a value of 24.7Ϯ3.7% when ␤␥-Imido ATP was not present (nϭ3; PϾ0.05; Fig. 3B ).
ATP analogues do not bind to hippocampal adenosine A 2A receptors
Since adenosine A 2A receptors antagonists prevented the facilitatory effect of ATP analogues on LTP, we sought to exclude the possibility that ATP analogues might directly interact with adenosine A 2A receptors. For that purpose, we carried out displacement binding curves to investigate the ability of ATP analogues to displace the binding of the selective A 2A receptor agonist [ 3 H]CGS 21680 to rat hippocampal membranes. As shown in Fig. 4 , both ␣␤-MeATP and ␤␥-Imido ATP failed to displace the binding of [ 3 H]CGS 21680 (30 nM) to rat hippocampal membranes in concentrations up to 100 M. This indicates that the tested ATP analogues are unable to interact directly with adenosine A 2A receptors in the rat hippocampus, similarly to what was previously observed in the striatum (Pirotton and Boeynaems, 1993) . We also found that PPADS also failed (Fig. 4) .
ATP analogues trigger [ 3 H]adenosine outflow from rat hippocampal slices
Another hypothesis that would reconcile the simultaneous involvement of P2 and A 2A receptors in the facilitation of LTP by ATP analogues would be a P2 receptor-induced release of adenosine that would then activate adenosine A 2A receptors. Thus, we investigated if ATP analogues could trigger adenosine outflow from rat hippocampal slices. Fig. 5a shows that ␤␥-Imido ATP (20 M) induced a release of tritium from hippocampal slices previously labelled with [ 3 H]adenosine to a value 147.7Ϯ2.3% greater than baseline (nϭ4; PϽ0.05). The P2 receptor antagonists, PPADS (10 M; nϭ4) and suramin (75 M; nϭ3; data not shown), were devoid of effects on basal tritium outflow but prevented this facilitatory effect of ␤␥-Imido ATP (20 M) on tritium outflow (Fig. 5A) .
We then tried to explore if there was any particular component in the slices that might contribute more intensely for this ATP-induced adenosine release. As illustrated in Fig. 5B , ␤␥-Imido ATP (20 M) triggered an outflow of tritium that was greater in nerve terminals (nϭ4) than in slices (nϭ3) and had similar amplitude in slices and in cultured astrocytes (nϭ3). The ␤␥-Imido ATP (20 M)-induced outflow of tritium from cultured neurons (nϭ4) was consistently lower than in all other tested hippocampal preparations (Fig. 5B) . This suggests that the P2 receptorevoked release of adenosine may mainly be derived from nerve terminals and astrocytes although it should be kept in mind that the expression and function of P2 receptors and nucleoside transporters may be modified in cultured neurons or astrocytes. We also confirmed that ␤␥-Imido
ATP (20 M) indeed enhanced [
3 H]adenosine release. In fact, ␤␥-Imido ATP (20 M) enhanced by 216Ϯ12% the outflow of adenosine from hippocampal nerve terminals (nϭ3). This indicates that tritium release might be a good measure of adenosine release and show that nerve terminals might be major contributors for this P2 receptor-induced release of adenosine.
Adenosine transport blockers prevent the ATP-induced [ 3 H]adenosine outflow
The extracellular accumulation of adenosine may result from two different sources: either from a release of adenosine as such through the bi-directional non-concentrative nucleoside transporters or from the formation of adenosine by the extracellular catabolism of released adenine nucleotides (Cunha, 2001) . We tested the ability of inhibitors of nucleoside transporters, dipyridamole and NBTI, to modify the P2 receptor-induced outflow of adenosine from rat hippocampal slices. We observed that the simultaneous presence of NBTI (5 M) and dipyridamole (10 M) virtually abolished the ability of ␤␥-Imido ATP (20 M) to trigger tritium outflow from rat hippocampal slices previously labelled with [ 3 H]adenosine (Fig. 5A ). This strongly suggests that the ATP-induced outflow of adenosine might essentially result from a release of adenosine mediated by the bi-directional non-concentrative adenosine transporters.
Adenosine transport blockers prevent the facilitatory effect of ATP analogues on LTP
To further reinforce our hypothesis that the facilitation by ATP analogues of hippocampal LTP involves a P2 receptor-mediated release of adenosine followed by activation of adenosine A 2A receptors, we tested the effect of NBTI and dipyridamole on the facilitatory effect of ␤␥-Imido ATP (20 M) on LTP. The facilitatory effect of ␤␥-Imido ATP (20 M) on LTP was prevented in the presence of NBTI (5 M) and dipyridamole (10 M), a value of 12.4Ϯ2.9% being obtained in the presence of NBTI, dipyridamole and ␤␥-Imido ATP, compared with a value of 15.5Ϯ1.2% when ␤␥-Imido ATP was not present (nϭ3; Fig. 6 ).
Activation of adenosine A 2A receptors facilitates LTP and occludes the facilitation of LTP by ATP analogues
If indeed adenosine A 2A receptor activation occurs downstream of P2 receptor activation, then an exogenously added high affinity agonist of A 2A receptors should by itself facilitate -burst LTP. In fact, the prototypical A 2A receptor agonist, CGS 21680 (10 nM), enhanced -burst LTP, a value of 47.7Ϯ2.7% being obtained in the presence of CGS 21680 (10 nM), compared with a value of 32.6Ϯ5.6% in the absence of CGS 21680 (nϭ3; PϽ0.05; Fig. 7A ).
Also, if the P2 receptor-mediated facilitation of LTP indeed depends on adenosine release followed by A 2A receptor activation then one would expect that the direct activation of A 2A receptors with CGS 21680 should occlude the facilitation of LTP by ATP analogues. As predicted, CGS 21680 (10 nM) prevented the facilitation of LTP by ␤␥-Imido ATP (20 M), a value of 32.1Ϯ6.6% being obtained in the presence of CGS 21680 and ␤␥-Imido ATP, compared with 30.4Ϯ5.3% in the absence of ␤␥-Imido ATP (nϭ3; PϾ0.05; Fig. 7B ).
Protein kinase C, but not protein kinase A, prevents the facilitatory effect of ATP analogues on LTP
The results so far obtained show that the effect of ATP analogues on LTP requires the recruitment of adenosine A 2A receptors after P2 receptor-induced adenosine release. Since adenosine A 2A receptor facilitation of hippocampal synaptic transmission requires the activation of protein kinase C but not protein kinase A (Cunha and Ribeiro, 2000b) , we tested the effect of the inhibitor of the protein kinase C, chelerythrine, on the facilitatory effect of ␤␥-Imido ATP on LTP. The facilitatory effect of ␤␥-Imido ATP (20 M) on LTP was prevented by chelerythrine (6 M), a value of 24.5Ϯ3.2% being obtained in the presence of chelerythrine and ␤␥-Imido ATP compared with a value of 24.1Ϯ3.2% when ␤␥-Imido ATP was not present (nϭ2, Fig. 8A ). We also tested the effect of an inhibitor of the protein kinase A, H89, on the facilitatory effect of ␤␥-Imido ATP on LTP. The facilitatory effect of ␤␥-Imido ATP (20 M) on LTP was not prevented by H89 (1 M), a value of 35.9Ϯ4.1% being obtained in the presence of H89 and ␤␥-Imido ATP compared with a value of 21.8Ϯ2.7% when ␤␥-Imido ATP was not present (nϭ2; Fig. 8B ).
DISCUSSION
The present results show that the modulation by extracellular ATP analogues of -burst-induced LTP in rat hippocampal slices requires the activation of P2 receptors, but ultimately depends on the induced release of adenosine and activation of adenosine receptors. Upon blockade of inhibitory adenosine A 1 receptors, ATP activates P2 receptors that trigger an enhanced adenosine outflow through nucleoside transporters, particularly from nerve terminals and astrocytes, and this released adenosine then activates facilitatory A 2A receptors causing an enhancement of LTP via a protein kinase C-dependent pathway.
Under basal frequencies of stimulation in rat hippocampal slices (one stimulus every 20 s), the effects of exogenously added ATP analogues are due to A 1 receptor activation upon extracellular catabolism of ATP into adenosine through the ecto-nucleotidase pathway (Dunwiddie et al., 1997; Cunha et al., 1998) . Although in Schaffer fibre synapses it is possible to reveal a minor component of the excitatory postsynaptic current mediated by P2X receptors (Pankratov et al., 1998 (Pankratov et al., , 2002 , it is observed that both the neuromodulatory effects and the direct effects of exogenously added ATP on the post-synaptic component are abolished by selective blockade of adenosine A 1 receptors (Dunwiddie et al., 1997) and are not observed in A 1 receptor knockout animals (Masino et al., 2002) . In fact, the kinetic efficiency of the ecto-nucleotidase pathway determines a fast and localised catabolism of adenine nucleotides into adenosine and the channelling of the minor amounts of adenosine formed to the highly abundant A 1 receptors (Dunwiddie et al., 1997; Cunha et al., 1998) , and this occurs both presynaptically (Cunha et al., 1998) and postsynaptically (Dunwiddie et al., 1997) . We now found that the same occurs during -burst LTP, i.e. that exogenously added ATP analogues inhibited LTP in a way reminiscent of the known inhibitory effects of adenosine on LTP (de Mendonça and Ribeiro, 1990; Arai et al., 1990) . Indeed, this inhibitory effect of ATP analogues on LTP was prevented by DPCPX, but was not modified by the P 2 receptor antagonists, PPADS or suramin, indicating that the inhibitory effects were due to the formation of adenosine, and did not involve a P2 receptor-mediated action, as recently suggested in clamped pyramidal neurons (Pankratov et al., 2002) . ATP analogues can thus exert inhibitory effects on LTP, which are apparently not mediated by purinergic P2 receptors and involve formation of adenosine acting through adenosine A 1 receptors. This likely results from the broad distribution of ecto-nucleotidases in different cell types in the CNS (reviewed by Zimmermann and Braun, 1999) and to the abundance and broad distribution of A 1 receptors in the hippocampus (e.g. Fastbom et al., 1987) that biases the effect of exogenously added ATP analogues. In fact, we have previously shown that exogenously added and endogenously released adenine nucleotides produce opposite effects in the modulation of hippocampal synaptic transmission (Cunha et al., 1996c) . Indeed, we now observed that, when blocking the adenosine A 1 receptors, excitatory effects for the ATP analogues could be revealed, which were genuinely mediated by P2 receptors, since they were blocked by the P2 receptor antagonists, PPADS or suramin.
At this stage, it is not possible to reliably study the role of endogenously released ATP on LTP since the available antagonists of P2 receptors also interfere with different ionotropic receptors, namely with NMDA receptor function (Nakazawa et al., 1995; Ong et al., 1997; Peoples and Li, 1998) , 1983) . Thus, we studied the mechanisms involved in these excitatory effects of the ATP analogues on LTP, which might be of particular relevance since ATP is released from stimulated hippocampal nerve terminals (Cunha et al., 2000) and the release of ATP is disproportionally larger upon conditions of stimulation known to induce LTP Cunha et al., 1996) . As previously justified, it is only possible and reasonable to study the role of P2 receptors upon blockade of A 1 receptors. There are, at present, few compounds selective for either P2X or P2Y receptor subtypes. The observation that NF023, an antagonist moderately selective for the P2X 1/3 subunit containing receptors (Soto et al., 1999; Lambrecht, 2000) , prevented the facilitatory effects of ATP analogues on LTP suggests that these receptor subtypes might be involved, a contention that is reinforced by the immunological confirmation of the localisation of P2X1, P2X2 and P2X3 receptor subunits in hippocampal nerve terminals (Rodrigues et al., manuscript in preparation). However, a detailed pharmacological characterisation must await the availability of more selective compounds and, at this stage, it is not possible to exclude the eventual involvement of P2Y receptors.
The facilitatory effects of ATP analogues on LTP were prevented by two selective antagonists of adenosine A 2A receptors. This result was not unexpected, since activation of P2 receptors was proposed to induce the release of adenosine (Nikbakht and Stone, 2000a,b) and we had previously reported that endogenously released adenine nucleotides trigger A 2A receptor activation in the hippocampus at low frequencies of stimulation (Cunha et al., 1996c) . By directly measuring the amount of tritiated adenosine released from hippocampal slices, we confirmed that ATP analogues markedly enhanced the outflow of adenosine (Sperlagh et al., 2003) . It is important to emphasise that this enhanced adenosine outflow is actually due to de novo purine release rather than from the extracellular catabolism of the added ATP analogues since the former is tritiated whereas the latter are not. The observation that the inhibitors of adenosine transporters nearly blocked this P2 receptor-induced adenosine outflow strongly suggests that the enhanced levels of extracellular adenosine may essentially result from a release of adenosine as such (see Cunha, 2001 ). We also found that the facilitatory effects of the ATP analogues on LTP were prevented in the presence of the blockers of bi-directional non-concentrative nucleoside transporters, NBTI plus dipyridamole. The mechanism whereby activation of P2 receptors modifies the function of nucleoside transporters is at present unknown. But the increase in extracellular adenosine levels activating adenosine A 2A receptors seems to be mandatory for the facilitatory effects of the ATP analogues on LTP, since these effects were blocked by two adenosine A 2A receptor selective antagonists, ZM 241385 and SCH 58261. Activation of the adenosine A 2A receptors is known to facilitate LTP irrespective of A 1 receptor blockade (de Mendonça and Ribeiro, 1994) . We now replicated and extended this observation, showing that the adenosine A 2A receptor selective agonist, CGS 21680, facilitated burstinduced LTP and it has recently been reported that NMDA receptor activation bursts A 2A receptor-mediated modulation of hippocampal synaptic transmission (Nikbakht and Stone, 2001 ). In accordance with the previously observed coupling of adenosine A 2A receptors with protein kinase C rather than with protein kinase A (see Cunha and Ribeiro, 2000b) , we found that the facilitatory effect of the ATP analogues on LTP were prevented by a protein kinase C inhibitor, chelerythrine, but not by a protein kinase A inhibitor, H89.
Thus, the present results indicate that ATP, which is released upon stimulation conditions that induce LTP, activates P2 receptors that lead to facilitation of LTP by a adenosine A 2A receptor-mediated and protein kinase Cdependent pathway. This concatenated effect of P2 and P1 (A 2A ) receptors illustrates the tight interrelation between ATP and adenosine neuromodulatory systems and reinforces our previous contention (Cunha and Ribeiro, 2000) that blockade of ATP responses by P2 receptor antagonists does not exclude the involvement of P1 receptors in physiological effects triggered by ATP. Certainly, the present findings do not exclude that ATP released upon stimulation might exert other effects relevant for LTP not involving P2 receptors. In particular, ATP was reported to extracellularly phosphorylate membrane proteins (Fujii et al., 1995; Chen et al., 1996) , although the presently tested ATP analogues were selected because they are poor phosphate donors (Wieraszko and Ehrlich, 1994; Kimiura et al., 1985) . Interestingly, a brief decrease in the activities of the enzymes that metabolise ATP to adenosine, ecto-ATP diphosphohydrolase and ecto-5Ј-nucleotidase, was observed in the hippocampus when learning an inhibitory avoidance task (Bonan et al., 1998 (Bonan et al., , 2000 . We could speculate that this decreased catabolism would lead to higher levels of ATP acting upon P2 receptors to transiently facilitate the phenomena of synaptic plasticity important for memory acquisition.
In conclusion, the present work demonstrates a functional role for P2 receptors in the modulation of LTP that operate indirectly through induction of adenosine release.
